Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alavi A, Lakhani P, Mavi A, et al. (2004) PET: a revolution in medical imaging. Radiol Clin North Am 42:983–1001
Allal AS, Slosman DO, Kebdani T, et al. (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-(18F)fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59:1295–1300
Anzai Y (2004) Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging 15:103–111
Arias-Mendoza F, Smith MR, Brown TR (2004) Predicting treatment response in non-Hodgkin’s lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Acad Radiol 11:368–276
Artemov D (2003) Molecular magnetic resonance imaging with targeted contrast agents. J Cell Biochem 90:518–524
Barentsz JO, Engelbrecht M, Jager GJ, et al. (1999) Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 10:295–304
Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328:1237–1243
Brahme A (2004) Recent advances in light ion radiation therapy. Int J Radiat Oncol Biol Phys 58:603–616
Bulte JWM, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484–499
Bussels B, Goethals L, Feron M, et al. (2003) Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. Radiother Oncol 68:69–74
Buyyounouski MK, Horwitz EM, Uzzo RG, et al. (2004) The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 59:1383–1391
Chao KS, Bosch WR, Mutic S, et al. (2001) A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49:1171–1182
Chapman JD, Bradley JD, Eary JF, et al. (2003) Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys 55:294–301
Coakley FV, Qayyum A, Kurhanewicz J (2003) Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 170:S69–S75
Daisne JF, Duprez T, Weynand B, et al. (2004) Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233:93–100
Dawson LA, Brock KK, Kazanjian S et al. (2001) The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51:1410–1421
Delbeke D, Martin WH (2004) PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 34:209–223
DiBiase SJ, Hosseinzadeh K, Gullapalli RP, et al. (2002) Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52:429–438
Dyke JP, Panicek DM, Healey JH, et al. (2003) Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 228:271–278
Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608
Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683–693
Gregoire V (2004) Is there any future in radiotherapy planning without the use of PET: unraveling the myth. Radiother Oncol 73:261–263
Haas RL, de Jong D, Valdes Olmos RA, et al. (2004) In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys 59:782–787
Harisinghani MG, Barentsz J, Hahn PF, et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499
Kalff V, Hicks RJ, MacManus MP, et al. (2001) Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 19:111–118
Kartachova M, Haas RL, Valdes Olmos RA, et al. (2004) In vivo imaging of apoptosis by (99m)Tc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 72:333–339
Keall P (2004) 4-Dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol 14:81–90
Lardinois D, Weder W, Hany TF, et al. (2003) Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507
Leibel SA, Fuks Z, Zelefsky MJ, et al. (2002) Intensity-modulated radiotherapy. Cancer J 8:164–176
Ling CC, Humm J, Larson S, Amols H, et al. (2000) Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47:551–560
Liu WC, Schulder M, Narra V et al. (2000) Functional magnetic resonance imaging aided radiation treatment planning. Med Phys 27:1563–1572
Mah D, Freedman G, Milestone B, et al. (2002) Measurement of intrafractional prostate motion using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 54:568–575
Mardor Y, Roth Y, Ochershvilli A, et al. (2004) Pretreatment prediction of brain tumors’ response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6:136–142
Mizowaki T, Cohen GN, Fung AY, et al. (2002) Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 54:1558–1564
Morawski AM, Winter PM, Crowder KC, et al. (2004) Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 51:480–486
Nehmeh SA, Erdi YE, Pan T, et al. (2004) Quantitation of respiratory motion during 4D PET/CT acquisition. Med Phys 31:1333–1338
Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16:407–422
Pieterman RM, van Putten JW, Meuzelaar JJ, et al. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254–261
Pickett B, Ten Haken RK, Kurhanewicz J, et al. (2004) Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 59:665–673
Pirzkall A, Li X, Oh J, et al. (2004) 3D MRSI for resected highgrade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 59:126–137
Pollack A, Hanlon AL, Horwitz EM, et al. (2004) Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol 171:1132–1136
Poulakis V, Witzsch U, de Vries R, et al. (2004) Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. Urology 64:1165–1170
Rasch C, Barillot I, Remeijer P, et al. (1999) Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43:57–66
Remouchamps VM, Letts N, Yan D, et al. (2003) Three-dimensional evaluation of intra-and interfraction immobilization of lung and chest wall using active breathing control: A reproducibility study with breast cancer patients. International Int J Radiat Oncol Biol Phys 57:968–978
Roach M 3rd, Faillace-Akazawa P, Malfatti C, et al. (1996) Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35:1011–1018
Rouviere O, Valette O, Grivolat S, et al. (2004) Recurrent prostate cancer after external beam radiotherapy: value of contrastenhanced dynamic MRI in localizing intraprostatic tumorcorrelation with biopsy findings. Urology 63:922–927
Sakr WA, Grignon DJ, Crissman JD, et al. (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 8:439–443
Steenbakkers RJ, Deurloo KE, Nowak PJ, et al. (2003) Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 57:1269–1279
Van de Wiele C, Lahorte C, Oyen W, et al. (2003) Nuclear medicine imaging to predict response to radiotherapy: a review. Int J Radiat Oncol Biol Phys 55:5–15
Wang L, Mullerad M, Chen HN, et al. (2004) Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 232:133–139
Weinmann HJ, Ebert W, Misselwitz B, et al. (2003) Tissue-specific MR contrast agents. Eur J Radiol 46:33–44
Zakian KL, Koutcher JA, Ballon D, et al. (2001) Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology. Semin Radiat Oncol 11:3–15
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Claus, F., Hricak, H. (2006). Imaging in Radiation Therapy. In: Levitt, S.H., Purdy, J.A. (eds) Technical Basis of Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-35665-7_4
Download citation
DOI: https://doi.org/10.1007/3-540-35665-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21338-3
Online ISBN: 978-3-540-35665-3
eBook Packages: MedicineMedicine (R0)